| Name | Title | Contact Details |
|---|---|---|
John Kelly |
Chief Information Officer | Profile |
ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company. The Company`s laboratory testing subsidiary, ProPhase Diagnostics, offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through both saliva and nasal swab methods at its CLIA certified laboratories. Critical to Covid testing, results are typically provided in under 24 hours. ProPhase Diagnostics also provides Respiratory Pathogen Panel (RPP) Molecular tests including Influenza A and B and others. ProPhase Labs researches, develops, manufactures, distributes, markets and sells OTC consumer healthcare products and dietary supplements, including dietary supplements under the TK Supplements® brand. The Company actively pursues strategic investments and acquisition opportunities for other companies, technologies and products.
Shore Health System provides an array of programs to attract, educate, and transition new and returning nurses.
HealthLink Innovations is a company that provides personalized home health care solutions to improve the patient and their familys quality of life.
AFID Therapeutics is a Lansing, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AccentHealth is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.